Ultragenyx Pharmaceutical’s Fayuvi is now the first FDA-approved therapy for the underlying cause of Sanfilippo syndrome type ...

Trump’s $500 ACA refunds offer immediate financial relief to some enrollees, but healthcare experts question whether they address the broader affordability challenges facing Americans.

Historically, warming and positioning have been addressed independently because, in many surgical procedures, they do not ...

Novartis is acquiring a Sironax platform technology designed to transport a range of drug modalities across the protective ...

As Medicare Advantage denial rates climb, health systems are dropping plans and steering patients back to traditional ...

North Immunology is going public in a reverse merger with Aethlon Medical. With eczema as the lead indication, the inflammation and immunology biotech aims to show its bispecific antibody offers ...

The Series C funding round was from The General Partnership, Index Ventures, General Catalyst and Andreessen Horowitz.

Hospitals' operating margins fell to 1.4% in July, down from 2.2% in May and June, according to new data from Kaufman Hall.

Flare Capital Partners led the Series A round. Craft, Obvious Ventures, Eniac Ventures, InHealth Ventures, Epsilon Health ...

Inspiren, a company selling an AI-powered senior living platform, raised $70 million in Series C funding led by NewView ...

After a near-miss with her own breast cancer diagnosis, Ariel Ganz co-founded Arben Ventures, a precision health and ...

Forus' $150 million Series C round was led by Bain Capital Ventures, with participation from Thrive Capital, General Catalyst ...